Skip to main content
Top

Clinical and Translational Oncology

Issue 5/2010

Content (12 Articles)

Editorial

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

Ferran Guedea, Alfredo Ramos, Ismael Herruzo, José Antonio Sánchez Calzado, Jorge Contreras, Jesús Romero, Jordi Craven-Bartle, Patricia Willisch, José Luis López Torrecilla, Xavier Maldonado, Gemma Sancho, Almudena Zapatero, Montserrat Ferrer, Yolanda Pardo, Pablo Fernández, Alfonso Mariño, Asunción Hervás, Víctor Macías, Ana Boladeras, Ferran Ferrer, Brian J. Davis

News and Views

A Law for Science

Enrique García Jordá

Educational Series

Lymphoma of the testis as primary location: tumour review

Georgios Koukourakis, Vassilios Kouloulias

Educational Series

The insulin-like growth factor pathway as a target for cancer therapy

Iker López-Calderero, Elizabeth Sánchez Chávez, Rocío García-Carbonero

Educational Series

The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment

Carmen Faus, Desamparados Roda, Matteo Frasson, Susana Roselló, Eduardo García-Granero, Blas Flor-Lorente, Samuel Navarro

Educational Series

Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment

Francesc Casas, Josep María Borràs, Ferran Ferrer, Núria Guanyabens, Rafael Gutiérrez del Pozo, Concha León, José López Torrecilla, Begoña Mellado, Joan Morote, Manel Puig, María José Ribal, Carme Ruscalleda, Agustí Serra, Valentí Valls, Almudena Zapatero

Special Article

TTD consensus document on the diagnosis and management of hereditary colorectal cancer

Pedro Pérez Segura, Carmen Guillén Alonso, Teresa Ramón y Cajal, Raquel Serrano Blanch, Enrique Aranda

Research Article

Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning

Antoni Vila, Alberto Sánchez-Reyes, Carles Conill, Juan Domingo Gispert, Carlos Trampal, Carmen Láinez, Jordi Vayreda, Agustí Pedro

Research Articles

Use of an electron spoiler for radiation treatment of surface skin diseases

Víctor Hernández, Alberto Sánchez-Reyes, Andreu Badal, Antoni Vila, Encarna Mur, Agustí Pedro, Francisco Sanchiz

Case Reports

Haemolytic uraemic syndrome associated with gemcitabine

Irene Moya-Horno, Rosa Querol Niñerola, Teresa Bonfill Abella, Elsa Dalmau Pórtulas, Enrique Gallardo-Díaz, Eugeni Saigí Grau, Carles Pericay Pijaume

Case Reports

Rituximab monotherapy in relapsed lymphocyte-predominant Hodgkin’s lymphoma

Laura Galán, Antonio C. Sánchez, Blanca Cantos, Mariano Provencio

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine